IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, to.
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) shot up 1% during mid-day trading on Friday . The company traded as high as $9.30 and last traded at $8.93. 87,418 shares were traded during mid-day trading, an increase of 3% from the average session volume of 84,853 shares. The stock had previously closed at […]
31.05.2023 - IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) - Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial .
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.